Prime Medicine, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Cambridge, MA
SEC filing record 1 source field available
Fiscal year end
31 December
Prime Medicine, Inc. has filed 287 SEC EDGAR filings since 20 Dec 2021

SEC filing history

Showing 76-100 of 287 matching filings.

Per page
25
Current page
4
ARS File 001-41536

ARS

Filing date
22 Apr 2025
Reporting date
31 Dec 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-41536

DEFA14A

Filing date
22 Apr 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-41536

DEF 14A

Filing date
22 Apr 2025
Reporting date
31 Dec 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
04 Mar 2025
Reporting date
28 Feb 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
03 Mar 2025
Reporting date
27 Feb 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
03 Mar 2025
Reporting date
27 Feb 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
03 Mar 2025
Reporting date
27 Feb 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
03 Mar 2025
Reporting date
27 Feb 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
03 Mar 2025
Reporting date
27 Feb 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
03 Mar 2025
Reporting date
27 Feb 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 File 333-285396

S-8

Filing date
28 Feb 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G/A File 005-93800

SCHEDULE 13G/A filing

Filing date
14 Feb 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-283780

EFFECT filing

Filing date
20 Dec 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
18 Dec 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD File 333-283780

UPLOAD filing

Filing date
17 Dec 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-3 File 333-283780

S-3

Filing date
13 Dec 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
09 Dec 2024
Reporting date
05 Dec 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
09 Dec 2024
Reporting date
05 Dec 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
09 Dec 2024
Reporting date
05 Dec 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-93800

ARCH VENTURE FUND XII, L.P. - PRIME MEDICINE -- SCH 13D/A(#1)

Filing date
22 Nov 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .